CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CURE seeks to explore the use of bacteriophages for treating asthma by restoring balance to the respiratory microbiome. The project aims to develop predictive models and phage preparations to control immune responses and improve asthma management.
The asthma pandemic imposes a huge burden on patients and health systems in both developed and developing countries.
Notwithstanding major efforts in untangling its pathophysiology, we are not even close to reaching a cure.
Despite available treatments, symptom control is generally suboptimal and hospitalisations and deaths remain at unacceptably high levels.
This calls for disruptive innovation towards a long-term treatment strategy.
Asthma is an inflammatory condition associated with immune de…
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Manchester
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Davos Platz
Type: Research institute
Activity type: Research Organisations
SME: Yes
BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS
Greece, Athina
Type: Research institute
Activity type: Research Organisations
SME: No
Poland, Lodz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
